Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty Liver
NCT ID: NCT02669316
Last Updated: 2016-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
660 participants
OBSERVATIONAL
2008-01-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Mediterranean Diet on Non-alcoholic Fatty Liver Disease
NCT01798719
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine
NCT03300661
Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease
NCT01894438
Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease
NCT06026293
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity
NCT04442620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Cancer
* virus hepatitis
* alcohol habits above 20 g/day (140 g/week) and any binge drinking
* myocardial infarction,
* valvular or congenital heart disease
* heart failure
* respiratory or renal insufficiency
* rheumatic or autoimmune disease.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guglielmo Trovato, MD, PhD
Dirigente Medico
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GUGLIELMO TROVATO, MD
Role: PRINCIPAL_INVESTIGATOR
University of Catania - Policlinico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Guglielmo Trovato
Catania, CT, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CARDIONAFLD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.